A medical affairs team used a 17-day Within3 virtual advisory board to gather internal feedback on training.
The team needed feedback on its training approach and digital features during COVID-19. It ran a 17-day virtual board with 31 US trainers and therapeutic area managers. The page reports changes could be made in days rather than weeks and that a repeatable process was established.
Within3 is a medical affairs insights platform, used by pharma for virtual advisory boards and AI-supported insights reporting from field, trial and social data
This sits in the Design & Stress-Test stage of the AI use-case lifecycle: Named examples from the tools pharma teams use to scope, prototype and benchmark an AI use case before committing to build it — data-catalog, sandbox and evaluation platforms.
Published by Within3 on its own site — read the original case study on within3.com ↗
Note: Page describes a collaboration platform; AI is not named.
Related use cases
- 01A top-5 pharma used Within3's AI-powered Launch Intelligence to find mental health professionals as an unplanned prescriber segment.
- 02A top pharma used Within3's Launch Intelligence to address diagnostic delays for a chronic gastrointestinal condition.
- 03A midsize pharma's medical affairs team replaced manual insight reporting with Within3's AI-supported Insights Reporting.
- 04A global pharma unified fragmented medical and commercial intelligence on Within3 for a launch in an unfamiliar therapeutic area.
- 05A multinational pharma trained 700+ investigators and site staff for a Phase 3 breast cancer trial on Within3's learning hub.
- 06A medical affairs team ran two asynchronous virtual advisory boards across four European countries on Within3.